Financial Factors and the Implementation of Medications for Treating Opioid Use Disorders
- 1 December 2012
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Journal of Addiction Medicine
- Vol. 6 (4), 280-286
- https://doi.org/10.1097/adm.0b013e318262a97a
Abstract
Objectives: Despite the established effectiveness of pharmacotherapies for treating opioid use disorders, implementation of medications for addiction treatment (MAT) by specialty treatment programs is limited. This research examined relationships between organizational factors and the program-level implementation of MAT, with attention paid to specific sources of funding, organizational structure, and workforce resources. Methods: Face-to-face structured interviews were conducted in 2008 to 2009 with administrators of 154 community-based treatment programs affiliated with the National Institute on Drug Abuse's Clinical Trials Network; none of these programs exclusively dispensed methadone without offering other levels of care. Implementation of MAT was measured by summing the percentages of opioid patients receiving buprenorphine maintenance, methadone maintenance, and tablet naltrexone. Financial factors included the percentages of revenues received from Medicaid, private insurance, criminal justice, the Federal block grant, state government, and county government. Organizational structure and workforce characteristics were also measured. Results: Implementation of MAT for opioid use disorders was low. Greater reliance on Medicaid was positively associated with implementation after controlling for organizational structure and workforce measures, whereas the association for reliance on criminal justice revenues was negative. Conclusions The implementation of MAT for opioid use disorders by specialty addiction treatment programs may be facilitated by Medicaid but may be impeded by reliance on funding from the criminal justice system. These findings point to the need for additional research that considers the impact of organizational dependence on different types of funding on patterns of addiction treatment practice.Keywords
This publication has 45 references indexed in Scilit:
- Barriers to the implementation of medication-assisted treatment for substance use disorders: The importance of funding policies and medical infrastructureEvaluation and Program Planning, 2011
- Using medication-assisted treatment for substance use disorders: Evidence of barriers and facilitators of implementationAddictive Behaviors, 2011
- Methadone and buprenorphine prescribing and referral practices in US prison systems: Results from a Nationwide SurveyDrug and Alcohol Dependence, 2009
- Top Manager Effects on Buprenorphine Adoption in Outpatient Substance Abuse Treatment ProgramsThe Journal of Behavioral Health Services & Research, 2009
- Treating Drug Abuse and Addiction in the Criminal Justice SystemPublished by American Medical Association (AMA) ,2009
- Alcohol and opioid dependence medications: Prescription trends, overall and by physician specialtyDrug and Alcohol Dependence, 2009
- Implementation of Evidence-Based Practices for Treatment of Alcohol and Drug Disorders: The Role of the State AuthorityThe Journal of Behavioral Health Services & Research, 2008
- Treatment programs in the National Drug Abuse Treatment Clinical Trials NetworkDrug and Alcohol Dependence, 2008
- Innovation adoption in substance abuse treatment: Exposure, trialability, and the Clinical Trials NetworkJournal of Substance Abuse Treatment, 2007
- The adoption of medications in substance abuse treatment: Associations with organizational characteristics and technology clustersDrug and Alcohol Dependence, 2007